Spnib 50 Mg

Spnib 50 Mg Specification

Indication
Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (Ph+ ALL)

Packaging Type
Box

Origin of Medicine
India

Brand Name
Spnib 50

Pacakaging (Quantity Per Box)
60 tablets per box

Life Span
Check package for expiry date (typically 2 years from manufacturing)

Salt Composition
Dasatinib IP 50 mg

Dosage Form
Tablet

Drug Type
Prescription Medicine

Ingredients
Dasatinib

Physical Form
Tablet

Function
Anti-cancer (used in the treatment of leukemia)

Recommended For
Adults and Children with certain types of leukemia

Dosage
As directed by physician

Dosage Guidelines
Take orally, dosage as prescribed by physician

Suitable For
Suitable for adults and children over 18 years

Quantity
60 Tablets

Storage Instructions
Store in a cool, dry place below 30C

ATC Code
L01XE06

Colour
Film-coated tablet

Strength
50 mg

Route of Administration
Oral

Warning
To be sold by retail on the prescription of an oncologist only

Prescription Required
Yes

Patient Advice
Keep out of reach of children. Not for use during pregnancy unless prescribed.

Approval
Approved by Drug Regulatory Authorities

Spnib 50 Mg Trade Information

Minimum Order Quantity
100 Bottles

Supply Ability
100 Bottles Per Day

Delivery Time
1 Days

About Spnib 50 Mg

Discover the resplendent efficacy of Spnib 50 Mg-an exceptional anti-cancer medication formulated with Dasatinib IP 50 mg. Designed for adults and children above 18 years, Spnib 50 conquers certain types of leukemia, offering a sublime solution approved by regulatory authorities. Each flawless film-coated tablet provides advanced treatment for Philadelphia chromosome-positive CML and Ph+ ALL. This prescription medicine ensures safety and precision, supplied in a secure box of 60 tablets. Shop now to avail a special rate and exclusive markdowns. Keep out of reach of children. Not for use during pregnancy unless prescribed.

Unlock Advanced Leukemia Treatment with Spnib 50 Mg

Spnib 50 Mg is widely recognized for its commercial utility in the management of Philadelphia chromosome-positive CML and Ph+ ALL. Its simple oral application method ensures convenience for patients. Chief competitive advantages include flawless efficacy, regulatory approval, and sublime formulation suitable for adults and children over 18. Trusted by oncologists, Spnib 50 delivers potent results, making it a preferred prescription option in leukemia care for reliable, measurable outcomes.

Global Certifications and Seamless Distribution of Spnib 50 Mg

Spnib 50 Mg boasts certifications from esteemed Drug Regulatory Authorities, affirming its safe and effective profile. With a strong footprint in international markets, this product is supplied through secure shipping and quick dispatch processes. Exported to key regions under strict compliance, potential buyers can rely on timely supply, flexible payment terms and efficient delivery, ensuring you receive genuine medication every time.

FAQ's of Spnib 50 Mg:

Q: How should Spnib 50 Mg be administered for best results?

A: Spnib 50 Mg should be taken orally as prescribed by your physician, following the exact dosage and instructions provided to ensure optimal efficacy and safety.

Q: What is the primary benefit of Spnib 50 Mg in leukemia treatment?

A: Spnib 50 Mg is primarily used for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (Ph+ ALL), offering targeted anti-cancer action approved by regulatory authorities.

Q: When should the dosage of Spnib 50 Mg be adjusted?

A: Dosage adjustments should only be made by your treating oncologist based on your individual response and medical condition. Never adjust the dosage without professional guidance.

Q: Where is Spnib 50 Mg manufactured and approved for use?

A: Spnib 50 Mg is manufactured in India and approved for use by Drug Regulatory Authorities, adhering to international standards of quality and patient safety.

Q: What safety advice should patients follow while using Spnib 50 Mg?

A: Patients should keep Spnib 50 Mg out of children's reach, store it below 30C in a cool, dry place, and avoid use during pregnancy unless specifically prescribed by a physician.